Apollomics Inc. SEC filings APLMW
Apollomics Inc. has 183 filings in SEC EDGAR's recent list, going back to Sep 14, 2022. Its latest annual report, Form 20-F, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 12, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Sep 8, 2026 | — |
| D | Filing | Aug 19, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 12, 2026 | Aug 11, 2026 |
| 6-K | Current report (foreign issuer) | Jul 21, 2026 | Jul 21, 2026 |
| 6-K | Current report (foreign issuer) | Jul 14, 2026 | Jul 14, 2026 |
| 6-K | Current report (foreign issuer) | Jun 24, 2026 | Jun 24, 2026 |
| EFFECT | Filing | Jun 2, 2026 | — |
| CORRESP | Letter to the SEC | May 28, 2026 | — |
| F-3/A | Filing | May 15, 2026 | — |
| 6-K | Current report (foreign issuer) | Apr 27, 2026 | Apr 27, 2026 |
| 20-F | Annual report (foreign issuer) | Apr 24, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Apr 1, 2026 | Apr 1, 2026 |
| UPLOAD | Letter from the SEC | Mar 11, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Mar 9, 2026 | — |
| S-8 | Employee stock plan registration | Feb 2, 2026 | — |
| 6-K | Current report (foreign issuer) | Dec 22, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Dec 12, 2025 | Dec 11, 2025 |
| 6-K | Current report (foreign issuer) | Nov 19, 2025 | Nov 19, 2025 |
| 6-K | Current report (foreign issuer) | Nov 18, 2025 | Nov 17, 2025 |
| 6-K | Current report (foreign issuer) | Oct 21, 2025 | Oct 21, 2025 |
| 6-K | Current report (foreign issuer) | Oct 16, 2025 | Oct 15, 2025 |
| 6-K | Current report (foreign issuer) | Oct 14, 2025 | Oct 14, 2025 |
| 6-K | Current report (foreign issuer) | Sep 25, 2025 | Sep 25, 2025 |
| 6-K | Current report (foreign issuer) | Sep 5, 2025 | Sep 5, 2025 |
| 6-K | Current report (foreign issuer) | Sep 3, 2025 | Sep 3, 2025 |
| 6-K | Current report (foreign issuer) | Aug 28, 2025 | Aug 28, 2025 |
| 6-K | Current report (foreign issuer) | Jul 25, 2025 | Jul 25, 2025 |
| 20-F | Annual report (foreign issuer) | Apr 3, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Apr 3, 2025 | Apr 3, 2025 |
| 6-K | Current report (foreign issuer) | Mar 31, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Dec 20, 2024 | Dec 20, 2024 |
| 6-K | Current report (foreign issuer) | Dec 10, 2024 | Dec 10, 2024 |
| 6-K | Current report (foreign issuer) | Nov 14, 2024 | Nov 14, 2024 |
| 6-K | Current report (foreign issuer) | Nov 1, 2024 | Nov 1, 2024 |
| 6-K | Current report (foreign issuer) | Aug 14, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | Aug 1, 2024 | Aug 1, 2024 |
| 6-K | Current report (foreign issuer) | Jul 16, 2024 | Jul 16, 2024 |
| 6-K | Current report (foreign issuer) | Jul 3, 2024 | Jul 3, 2024 |
| EFFECT | Filing | May 29, 2024 | — |
| 424B3 | Prospectus | May 29, 2024 | — |
| CORRESP | Letter to the SEC | May 28, 2024 | — |
| 6-K | Current report (foreign issuer) | May 24, 2024 | May 24, 2024 |
| 424B5 | Prospectus supplement | May 24, 2024 | — |
| UPLOAD | Letter from the SEC | May 24, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | May 20, 2024 | — |
| 6-K | Current report (foreign issuer) | May 8, 2024 | May 8, 2024 |
| 6-K | Current report (foreign issuer) | Apr 25, 2024 | Apr 25, 2024 |
| EFFECT | Filing | Apr 24, 2024 | — |
| EFFECT | Filing | Apr 24, 2024 | — |
| 424B3 | Prospectus | Apr 24, 2024 | — |
| 424B3 | Prospectus | Apr 24, 2024 | — |
| CORRESP | Letter to the SEC | Apr 22, 2024 | — |
| CORRESP | Letter to the SEC | Apr 22, 2024 | — |
| CORRESP | Letter to the SEC | Apr 19, 2024 | — |
| CORRESP | Letter to the SEC | Apr 19, 2024 | — |
| F-3/A | Filing | Apr 19, 2024 | — |
| F-3/A | Filing | Apr 19, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2024 | — |
| CORRESP | Letter to the SEC | Apr 12, 2024 | — |
| CORRESP | Letter to the SEC | Apr 12, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 1, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Apr 1, 2024 | — |
| 20-F | Annual report (foreign issuer) | Mar 28, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Mar 28, 2024 | Mar 28, 2024 |
| 424B3 | Prospectus | Mar 4, 2024 | — |
| 6-K | Current report (foreign issuer) | Mar 4, 2024 | Mar 4, 2024 |
| 6-K | Current report (foreign issuer) | Jan 19, 2024 | Jan 19, 2024 |
| 6-K | Current report (foreign issuer) | Jan 8, 2024 | Jan 8, 2024 |
| 424B3 | Prospectus | Nov 16, 2023 | — |
| 424B3 | Prospectus | Oct 26, 2023 | — |
| 424B3 | Prospectus | Oct 25, 2023 | — |
| EFFECT | Filing | Sep 29, 2023 | — |
| 424B3 | Prospectus | Sep 29, 2023 | — |
| POS AM | Filing | Sep 28, 2023 | — |
| 424B3 | Prospectus | Sep 28, 2023 | — |
| 6-K | Current report (foreign issuer) | Sep 28, 2023 | Jun 30, 2023 |
| 424B3 | Prospectus | Jul 25, 2023 | — |
| EFFECT | Filing | Jul 24, 2023 | — |
| 6-K | Current report (foreign issuer) | Jul 20, 2023 | Jul 20, 2023 |
| CORRESP | Letter to the SEC | Jul 20, 2023 | — |
| CORRESP | Letter to the SEC | Jul 7, 2023 | — |
| F-1/A | Filing | Jul 7, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 23, 2023 | — |
| S-8 | Employee stock plan registration | Jun 9, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Jun 9, 2023 | — |
| 20-F | Annual report (foreign issuer) | Apr 28, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2023 | Mar 29, 2023 |
| 6-K | Current report (foreign issuer) | Mar 30, 2023 | Mar 30, 2023 |
| CERT | Filing | Mar 29, 2023 | — |
| 8-A12B | Filing | Mar 28, 2023 | — |
| SEC STAFF LETTER | Filing | Mar 6, 2023 | — |
| EFFECT | Filing | Feb 28, 2023 | — |
| 424B3 | Prospectus | Feb 28, 2023 | — |
| CORRESP | Letter to the SEC | Feb 24, 2023 | — |
| CORRESP | Letter to the SEC | Feb 21, 2023 | — |
| F-4/A | Filing | Feb 21, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2023 | — |
| F-4/A | Filing | Feb 10, 2023 | — |
| 425 | Filing | Feb 10, 2023 | — |
| F-4/A | Filing | Dec 23, 2022 | — |
| CORRESP | Letter to the SEC | Dec 22, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2022 | — |
| F-4/A | Filing | Dec 15, 2022 | — |
| CORRESP | Letter to the SEC | Dec 14, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2022 | — |
| SEC STAFF LETTER | Filing | Dec 2, 2022 | — |
| CORRESP | Letter to the SEC | Nov 22, 2022 | — |
| F-4 | Filing | Nov 22, 2022 | — |
| 425 | Filing | Nov 15, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2022 | — |
| 425 | Filing | Oct 14, 2022 | — |
| 425 | Filing | Oct 7, 2022 | — |
| DRS | Filing | Sep 29, 2022 | — |
| 425 | Filing | Sep 15, 2022 | — |
| 425 | Filing | Sep 14, 2022 | — |
| 425 | Filing | Sep 14, 2022 | — |
| 425 | Filing | Sep 14, 2022 | — |
Showing 120 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- APLM (Nasdaq), APLMW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Covina, CA
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1944885
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.